XML 18 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Assets and Liabilities (USD $)
Sep. 30, 2014
Dec. 31, 2013
ASSETS    
Investment in palladium (cost: September 30, 2014: $377,237; December 31, 2013: $463,598) $ 448,419,000 [1],[2] $ 510,475,000
Investment in palladium, lower of cost or market value (cost: September 30, 2014: $377,237; December 31, 2013: $463,598)   463,598,000 [2],[3]
Total assets 448,419,000 [1] 463,598,000 [3]
LIABILITIES    
Fees payable to Sponsor 231,994 260,849
Palladium payable 3,766,000 0
Total Liabilities 3,998,000 [1] 261,000 [3]
NET ASSETS 444,421,000 [1] 463,337,000 [3]
ANALYSIS OF NET ASSETS    
Redeemable Shares at redemption value to investors 444,421,000 [1] 510,214,000 [3]
Shareholders’ deficit   (46,877,000) [3],[4]
Total net assets $ 444,421,000 [1] $ 463,337,000 [1],[3]
[1] Effective January 1, 2014, the Trust has adopted the provisions of Topic 946, Investment Companies, and follows specialized accounting. Refer to Note 2.1 for additional information.
[2] At September 30, 2014, the investment in palladium is recorded at fair value. At December 31, 2013, the investment in palladium was recorded at the lower of cost or market value. Refer to note 2.1 for a breakdown of cost and fair value of the investment in palladium.
[3] Derived from audited Statement of Financial Condition as of December 31, 2013. The amounts are those previously reported under non investment company accounting. Refer to Note 2.1 for additional information.
[4] Net assets at December 31, 2013 represents total liabilities, redeemable Shares and shareholders’ deficit. Authorized share capital is unlimited with no par value per Share. Shares issued and outstanding at September 30, 2014 were 5,900,000 and at December 31, 2013 were 7,350,000. Net asset value per Share at September 30, 2014 and December 31, 2013 was $75.33 and $69.42, respectively.